21 C.F.R. § 520.292

Capromorelin.

Last amended: 2021Year: 2026Length: 157 wordsSubsections: 4Official source

Cite as 21 C.F.R. § 520.292 (2026)

(a) Specifications. Each milliliter of solution contains: (1) 30 milligrams (mg) capromorelin; or (2) 20 mg capromorelin. (b) Sponsor. See No. 058198 in § 510.600(c) of this chapter. (c) Conditions of use —(1) Dogs. Use product described in paragraph (a)(1) of this section as follows: (i) Amount. Administer 3 mg/kg once daily by mouth. (ii) Indications for use. For appetite stimulation in dogs. (iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. (2) Cats. Use product described in paragraph (a)(2) of this section as follows: (i) Amount. Administer 2 mg/kg once daily by mouth. (ii) Indications for use. For management of weight loss in cats with chronic kidney disease. (iii) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian. [81 FR 59133, Aug. 29, 2016, as amended at 85 FR 4207, Jan. 24, 2020; 86 FR 17063, Apr. 1, 2021]
Cross-references to the CFR
510.600
21 C.F.R. § 520.292: Capromorelin. | Justis AI